15 insiders reported 185 Form 4 transactions for MapLight Therapeutics, Inc. (MPLT) over the past 18 months (most recent 2026-09-18). Recent activity: Hanson Kristopher (General Counsel) Sell 16,509 shares, Kroeger Christopher A. (Chief Executive Officer) Buy 23,145 shares, GILLIS JONATHAN (CAO and Interim CFO) Buy 6,020 shares, Lillie James Woodruff (Chief Scientific Officer) Buy 7,730 shares, Hanson Kristopher (General Counsel) Buy 7,730 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Hanson Kristopher | General Counsel | Sell | 16,509 | $192,660 |
| 2026-08-19 | Kroeger Christopher A. | Chief Executive Officer | Buy | 23,145 | $0 |
| 2026-08-19 | GILLIS JONATHAN | CAO and Interim CFO | Buy | 6,020 | $0 |
| 2026-08-19 | Lillie James Woodruff | Chief Scientific Officer | Buy | 7,730 | $0 |
| 2026-08-19 | Hanson Kristopher | General Counsel | Buy | 7,730 | $0 |
| 2026-08-19 | Foff Erin Pennock | Chief Medical Officer | Buy | 13,360 | $0 |
| 2026-08-19 | Kreitzer Anatol | Chief Discovery Officer | Buy | 6,020 | $0 |
| 2026-08-19 | GILLIS JONATHAN | CAO and Interim CFO | Buy | 2,222 | $0 |
| 2026-08-04 | Lillie James Woodruff | Chief Scientific Officer | Sell | 22,082 | $276,908 |
| 2026-07-28 | Cox Troy | Director | Buy | 15,620 | $148,702 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 4,699 | $173,581 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 5,545 | $200,341 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 5,356 | $193,512 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 4,510 | $166,599 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 6,979 | $255,850 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 7,464 | $273,630 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 1,476 | $55,261 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 1,592 | $59,604 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 600 | $21,906 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 2,833 | $104,963 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 16,969 | $638,204 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 14,140 | $533,078 |
| 2026-07-20 | GILLIS JONATHAN | CAO and Interim CFO | Sell | 900 | $34,353 |
| 2026-07-20 | Kreitzer Anatol | Chief Discovery Officer | Sell | 200 | $7,678 |
| 2026-07-17 | Kroeger Christopher A. | Chief Executive Officer | Sell | 18,950 | $682,200 |
Source: SEC Form 4 filings · as of 2026-09-18